×
About 85,485 results

ALLMedicine™ Schizophrenia Center

Research & Reviews  27,862 results

Associations of Duration of Preadoption Out-of-home Care, Genetic Risk for Schizophreni...
https://doi.org/10.1007/s10578-022-01411-x
Child Psychiatry and Human Development; Myllyaho T, Siira V et. al.

Aug 14th, 2022 - The objective was to examine the impacts of duration of preadoption out-of-home care and adoptive family functioning on later psychiatric morbidity of adoptees with high (HR) and low (LR) genetic risk for schizophrenia spectrum disorders. The stud...

Lineage analysis of Cxcr4-expressing cells in the developing midbrain suggests that pro...
https://doi.org/10.1523/ENEURO.0052-22.2022
ENeuro Petese A, Fries FL et. al.

Aug 13th, 2022 - Midbrain dopaminergic (mDA) neurons are generated from a ventral midbrain progenitor zone over a time span of several days (embryonic day (E)10.0-E14.5 in mouse). Within this neurogenic period, a progressively changing fate potential of mDA progen...

Perspectives of Nursing Students towards Schizophrenia Stigma: A Qualitative Study Prot...
https://doi.org/10.3390/ijerph19159574
International Journal of Environmental Research and Publi... Chen X, Su J et. al.

Aug 13th, 2022 - This study aims to explore fourth-year nursing students' knowledge of schizophrenia and their attitudes, empathy, and intentional behaviours towards people with schizophrenia. This will be a descriptive qualitative study using focus-group intervie...

Time in schizophrenia: a link between psychopathology, psychophysics and technology.
https://doi.org/10.1038/s41398-022-02101-x
Translational Psychiatry; Amadeo MB, Esposito D et. al.

Aug 13th, 2022 - It has been widely demonstrated that time processing is altered in patients with schizophrenia. This perspective review delves into such temporal deficit and highlights its link to low-level sensory alterations, which are often overlooked in rehab...

Trans-genetic effects of circular RNA expression quantitative trait loci and potential ...
https://doi.org/10.1038/s41380-022-01714-4
Molecular Psychiatry; Mai TL, Chen CY et. al.

Aug 13th, 2022 - Genetic risk variants and transcriptional expression changes in autism spectrum disorder (ASD) were widely investigated, but their causal relationship remains largely unknown. Circular RNAs (circRNAs) are abundant in brain and often serve as upstr...

see more →

Guidelines  10 results

The American Psychiatric Association Practice Guideline for the Treatment of Patients W...
https://doi.org/10.1176/appi.ajp.2020.177901
The American Journal of Psychiatry; Keepers GA, Fochtmann LJ et. al.

Sep 2nd, 2020 - The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.|2020|Keepers GA,Fochtmann LJ,Anzia JM,Benjamin S,Lyness JM,|methods,methods,methods,classification,therapeutic use,diagnosis,therapy,

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated r...
https://doi.org/10.1177/0269881119889296
Journal of Psychopharmacology (Oxford, England); Barnes TR, Drake R et. al.

Dec 13th, 2019 - These updated guidelines from the British Association for Psychopharmacology replace the original version published in 2011. They address the scope and targets of pharmacological treatment for schizophrenia. A consensus meeting was held in 2017, i...

EPA guidance on physical activity as a treatment for severe mental illness: a meta-revi...
https://doi.org/10.1016/j.eurpsy.2018.07.004
European Psychiatry : the Journal of the Association of E... Stubbs B, Vancampfort D et. al.

Sep 28th, 2018 - Physical activity (PA) may be therapeutic for people with severe mental illness (SMI) who generally have low PA and experience numerous life style-related medical complications. We conducted a meta-review of PA interventions and their impact on he...

BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascu...
https://doi.org/10.1177/0269881116645254
Journal of Psychopharmacology (Oxford, England); Cooper SJ, Reynolds GP et. al.

May 6th, 2016 - Excess deaths from cardiovascular disease are a major contributor to the significant reduction in life expectancy experienced by people with schizophrenia. Important risk factors in this are smoking, alcohol misuse, excessive weight gain and diabe...

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biologica...
https://doi.org/10.3109/15622975.2012.696143
The World Journal of Biological Psychiatry : the Official... Hasan A, Falkai P et. al.

Jul 28th, 2012 - These updated guidelines are based on a first edition of the World Federation of Societies of Biological Psychiatry Guidelines for Biological Treatment of Schizophrenia published in 2005. For this 2012 revision, all available publications pertaini...

see more →

Drugs  977 results see all →

Clinicaltrials.gov  2,961 results

Links Between Perception of Temporal Order Judgment and Causality in Schizophrenia
https://clinicaltrials.gov/ct2/show/NCT03432000

Aug 12th, 2022 - The objective of our work lies in the study of the links between temporal sequencing, subjective perception of time and causality. To carry out this work, the investigators will rely on an experimental paradigm (derived from Michotte's paradigm) w...

A Longitudinal Investigation of the Endocrine and Neurobiologic Events Accompanying Puberty
https://clinicaltrials.gov/ct2/show/NCT01434368

Aug 12th, 2022 - Despite the clear importance of adolescence in the emergence of a number of disease states and processes, there is surprisingly little known about how the endocrine and metabolic events accompanying puberty in humans impact normal developmental ne...

Cerebral Impact of Cognitive Remediation for People Suffering From Schizophrenia
https://clinicaltrials.gov/ct2/show/NCT04033978

Aug 12th, 2022 - Among cognitive deficits associated to schizophrenia, the jumping to conclusion bias is a frequent consequence of the decision making process alteration. This bias is characterized by a fast decision making when probabilistic judgments would be ne...

RC2S+: Remediation of Social Cognitive Impairments
https://clinicaltrials.gov/ct2/show/NCT02976077

Aug 12th, 2022 - Methods: This is a randomized controlled trial to establish the validity of the RC2S+ program in schizophrenia. The project's main objective is to assess the impact of RC2S+ on social cognitive impairments in schizophrenia compared with a cognitiv...

Neuronal Effects of Exercise in Schizophrenia
https://clinicaltrials.gov/ct2/show/NCT02455193

Aug 12th, 2022 - This study plans to learn more about how common drugs prescribed to individuals with schizophrenia contribute to weight gain, as well as how exercise and diet impact appetite and the brain's response to food. In this study, the investigators will ...

see more →

News  2,371 results

Positive Phase 3 Results for Novel Schizophrenia Drug
https://www.medscape.com/viewarticle/978964

Aug 9th, 2022 - The investigational agent xanomeline-trospium (KarXT, Karuna Therapeutics), which combines a muscarinic receptor agonist with an anticholinergic agent, helps improve psychosis symptoms, and is not associated with weight gain or sedation in adults ...

LAIAs Safer, More Effective Than Oral Antipsychotics for Schizophrenia
https://www.medscape.com/viewarticle/978720

Aug 5th, 2022 - For patients with schizophrenia, long-acting injectable antipsychotics (LAIAs) are associated with a lower risk than oral antipsychotics (OAs) for disease relapse and hospitalization ― and they carry no increased risk for adverse events, new resea...

Intranasal Oxytocin Fails to Enhance Emotional Connections
https://www.medscape.com/viewarticle/978648

Aug 4th, 2022 - Oxytocin nasal spray is unlikely to help young healthy men decipher emotional cues. In a controlled trial, oxytocin nasal spray did not improve the ability to recognize sad or angry faces, compared with a validated psychological emotion training p...

Antipsychotics in Schizophrenia: Effectiveness and Optimal Dosing
https://www.medscape.com/viewarticle/969527

Aug 2nd, 2022 - This transcript has been edited for clarity. John M. Kane, MD: Hi. I'm Dr John Kane, professor and chairman of psychiatry at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in New York, and also the Zucker Hillside Hospital i...

What Are the Major Metabolic and Neurologic Risks Associated With Antipsychotic Medications?
https://www.medscape.com/viewarticle/969525

Aug 2nd, 2022 - This transcript has been edited for clarity. John M. Kane, MD: Hi. I'm John Kane, professor and chairman of psychiatry at the Donald and Barbara Zucker School of Medicine in New York and also the Zucker Hillside Hospital. Welcome to Medscape's InD...

see more →

Patient Education  13 results see all →